Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Freyer

Showing results (1-10 of 145) with videos related to

Pageof 15
Sort By:
Bulletin Du Cancer|October 18, 2023
Gilles Freyer
Translational Cancer Research|December 11, 2025
Chemotherapy-free combination strategies in recurrent platinum-resistant ovarian cancer: promise, evidence and perspectivesPauline Corbaux, Gilles Freyer
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 6, 2011
Clinical trials and treatment of the elderly diagnosed with ovarian cancerGilles Freyer, Anna V Tinker,
Pharmacogenomics|September 17, 2011
Revisiting the frontiers of pharmacogenomics of colon cancerClaire Falandry, Marc Bonnefoy, Gilles Freyer
La Revue Du Praticien|April 1, 2003
[Treatment of cancer: surgery, radiotherapy, chemotherapy, hormonal therapy. Multidisciplinary therapeutic decision making and informing the patient]Christine Clippe, Véronique Trillet-Lenoir, Gilles Freyer
Clinical Drug Investigation|March 7, 2016
First-Line Treatments for Poor-Prognosis Metastatic Renal Cell Carcinoma: Experts' Prescribing Practices and Systematic Literature ReviewOlivia Le Saux, Gilles Freyer, Sylvie Négrier
JAMA Oncology|September 9, 2021
What Is the Optimal Treatment for Vulnerable Older Women With Ovarian Cancer?-ReplyClaire Falandry, Gilles Freyer, Eric Pujade-Lauraine
Clinical Breast Cancer|January 16, 2014
Antiangiogenic therapy in patients with HER2-positive metastatic breast cancer: a case seriesOlivia Le Saux, Benoît You, Gilles Freyer
Bulletin Du Cancer|March 28, 2003
[Dosage regimen optimization in cancer chemotherapy using a mathematical model]Dominique Barbolosi, Gilles Freyer, Joseph Ciccolini, et al.
Bulletin Du Cancer|September 13, 2007
[Metastatic prostate cancer treatment in the elderly]Claire Falandry, Marc Bonnefoy, Benoît You, et al.
Pageof 15

Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
Bulletin Du Cancer|October 18, 2023
Gilles Freyer
Translational Cancer Research|December 11, 2025
Chemotherapy-free combination strategies in recurrent platinum-resistant ovarian cancer: promise, evidence and perspectivesPauline Corbaux, Gilles Freyer
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 6, 2011
Clinical trials and treatment of the elderly diagnosed with ovarian cancerGilles Freyer, Anna V Tinker,
Pharmacogenomics|September 17, 2011
Revisiting the frontiers of pharmacogenomics of colon cancerClaire Falandry, Marc Bonnefoy, Gilles Freyer
La Revue Du Praticien|April 1, 2003
[Treatment of cancer: surgery, radiotherapy, chemotherapy, hormonal therapy. Multidisciplinary therapeutic decision making and informing the patient]Christine Clippe, Véronique Trillet-Lenoir, Gilles Freyer
Clinical Drug Investigation|March 7, 2016
First-Line Treatments for Poor-Prognosis Metastatic Renal Cell Carcinoma: Experts' Prescribing Practices and Systematic Literature ReviewOlivia Le Saux, Gilles Freyer, Sylvie Négrier
JAMA Oncology|September 9, 2021
What Is the Optimal Treatment for Vulnerable Older Women With Ovarian Cancer?-ReplyClaire Falandry, Gilles Freyer, Eric Pujade-Lauraine
Clinical Breast Cancer|January 16, 2014
Antiangiogenic therapy in patients with HER2-positive metastatic breast cancer: a case seriesOlivia Le Saux, Benoît You, Gilles Freyer
Bulletin Du Cancer|March 28, 2003
[Dosage regimen optimization in cancer chemotherapy using a mathematical model]Dominique Barbolosi, Gilles Freyer, Joseph Ciccolini, et al.
Bulletin Du Cancer|September 13, 2007
[Metastatic prostate cancer treatment in the elderly]Claire Falandry, Marc Bonnefoy, Benoît You, et al.
Pageof 15